2022
DOI: 10.1016/j.cmi.2022.01.021
|View full text |Cite
|
Sign up to set email alerts
|

Quantification of within-patient Staphylococcus aureus phenotypic heterogeneity as a proxy for the presence of persisters across clinical presentations

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3
3

Relationship

3
3

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 32 publications
(36 reference statements)
0
8
0
Order By: Relevance
“…Importantly, this phenomenon is sometimes observed in only a small proportion of the infecting strains (heterogenous phenotype) or is associated with frequent alternation between two phenotypic states (phase variation) 103 . Classic adaptive phenotypes include secondary antibiotic resistance (in particular subtle changes such as vancomycin-intermediate S. aureus and heterogeneous vancomycin-intermediate S. aureus ) 25 , 144 , 145 and small colony variants 146 , 147 . Recently, reduced eukaryotic cell toxicity was recognized as an important adaptive phenotype related to invasive S. aureus infections with a case of loss of toxicity in late colonizing strains that leads to infection with a low-toxicity strain 148 .…”
Section: Introductionmentioning
confidence: 99%
“…Importantly, this phenomenon is sometimes observed in only a small proportion of the infecting strains (heterogenous phenotype) or is associated with frequent alternation between two phenotypic states (phase variation) 103 . Classic adaptive phenotypes include secondary antibiotic resistance (in particular subtle changes such as vancomycin-intermediate S. aureus and heterogeneous vancomycin-intermediate S. aureus ) 25 , 144 , 145 and small colony variants 146 , 147 . Recently, reduced eukaryotic cell toxicity was recognized as an important adaptive phenotype related to invasive S. aureus infections with a case of loss of toxicity in late colonizing strains that leads to infection with a low-toxicity strain 148 .…”
Section: Introductionmentioning
confidence: 99%
“…Chemical Biology is providing an ever increasing toolset of next-generation physiology probes that report on diverse phenotypic traits from cellular permeability, specific biomolecular uptake pathways, replication, metabolic activity or the distribution and activity of specific molecular targets or groups in living bacterial cells (as reviewed in 33,66,67 ) and are exploitable for CPP. The use of exogenous fluorescent probes makes CPP highly compatible for applications in clinical samples 15 , allowing for direct detection and characterization of unstable phenotypic variants that would revert upon cultivation. We believe persisters and heteroresistant cells are only the most easily detected tip-of-the-iceberg of distinct subpopulation phenotypes in isogenic bacterial pathogen populations.…”
Section: Discussionmentioning
confidence: 99%
“…Alternatively, heterogeneity may result from necessary trait adjustments according to ´cellular vigor´ 6 . An increasing body of literature documents the clinical relevance and complications for treatment elicited by subpopulation phenotypes, particularly during chronic infections 9,10,[11][12][13][14][15] . This includes heteroresistant cells, i.e.…”
Section: Introductionmentioning
confidence: 99%
“…To further elucidate GAS survival in the host, we examined the ability of GAS to form persisters in patients with GAS-NF and mimicked the clinical situation in vitro. We postulated that conditions encountered in the host, such as the acidic pH found in abscesses, necrotic tissue or intracellularly in lysozymes and the presence of antibiotics used for treatment induce or select for a GAS sub-population resilient to antibiotic treatment [2, 18]. The three patients included in this study were treated with high antibiotic doses before surgery, according to current guidelines.…”
Section: Discussionmentioning
confidence: 99%